Assistance Publique - Hôpitaux de Paris: Vasculitis trials

The registry lists 20 Vasculitis studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 6Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
• A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO TrialRecruitingNCT05946564Phase 3
• Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory DiseasesRecruitingNCT05383339
• Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)RecruitingNCT04629144Phase 2
• Prospective Longitudinal Cohort Study of Vasculitis PatientsRecruitingNCT04413331
• Isatuximab in Type I CryoglobulinemiaStatus unknownNCT05114109Phase 2
• Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA VasculitisStatus unknownNCT04008316Phase 3
• Study of Refractory and/or Relapsing TAkayasu aRTeritisStatus unknownNCT03543527
• Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet DiseaseCompletedNCT03371095Phase 3
• Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia VasculitisStatus unknownNCT02856243
• Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia VasculitisTerminatedNCT02556866Phase 2
• Phenomics in Autoimmune and Inflammatory DiseasesCompletedNCT02466217
• Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated VasculitisStatus unknownNCT02463578
• Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated VasculitisCompletedNCT02463539
• Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
• Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env CohortCompletedNCT01314547
• Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
• Intravenous Immunoglobulin After Relapse in VasculitisTerminatedNCT00307658Phase 3
• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3